Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

by Anna Nagurney January 8, 2021, 12:53 pm
Does SARS-COV-2 Launch a Direct Viral Attack on the Brain?

by Global Biodefense Staff January 4, 2021, 1:46 pm
Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

by Global Biodefense Staff January 4, 2021, 1:01 pm
At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

by JoNel Aleccia, Kaiser Health News December 23, 2020, 12:36 pm
What is the Spike Protein and Why Are Mutations On It Important?

by Connor Bamford December 22, 2020, 12:11 pm
Key Questions on New Variant of SARS-CoV-2 Answered by UK Genomics Researcher

by Lucy van Dorp December 21, 2020, 10:40 am
FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

by Global Biodefense Staff December 19, 2020, 2:02 pm
Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

by JoNel Aleccia, Kaiser Health News December 14, 2020, 5:33 pm
Research Reveals How Airflow Inside a Car May Affect COVID-19 Transmission Risk

by Global Biodefense Staff December 6, 2020, 4:41 pm
Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

by Global Biodefense Staff December 4, 2020, 4:59 pm
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
How COVID-19 Vaccines Will Get From the Factory to Your Community

by Bahar Aliakbarian December 4, 2020, 9:25 am
Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

by Matthew Woodruff December 3, 2020, 10:52 am
CONVINCE USA Aims to Address Public Concerns About COVID-19 Vaccine

by Global Biodefense Staff December 2, 2020, 4:13 pm
Researchers Determine How SARS-CoV-2 Hijacks and Rapidly Damages Human Lung Cells

by Global Biodefense Staff December 2, 2020, 8:44 am

Congratulations. You've reached the end of the internet.

SARS-CoV-2

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

Does SARS-COV-2 Launch a Direct Viral Attack on the Brain?

Results of Comprehensive SARS-CoV-2 Non-Human Primate Study Published

At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine

What is the Spike Protein and Why Are Mutations On It Important?

Key Questions on New Variant of SARS-CoV-2 Answered by UK Genomics Researcher

FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use

Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots

Research Reveals How Airflow Inside a Car May Affect COVID-19 Transmission Risk

Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

How COVID-19 Vaccines Will Get From the Factory to Your Community

Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing

CONVINCE USA Aims to Address Public Concerns About COVID-19 Vaccine

Researchers Determine How SARS-CoV-2 Hijacks and Rapidly Damages Human Lung Cells

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles